CC1OC(O[C@H]2C3C=CO[C@@H](OC4OC(CO)C(O)C(O)C4O)C3[C@@]3(COC(=O)/C=C/c4ccccc4)O[C@@H]23)C(O)C(O)C1O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?